Portage Biotech Inc.
PRTG
$8.10
-$1.01-11.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -37.90% | 17.87% | 93.35% | 36.79% |
| Total Depreciation and Amortization | 0.00% | 42.86% | -12.50% | -38.46% | -13.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 566.48% | 90.95% | -104.56% | -38.94% |
| Change in Net Operating Assets | 0.00% | 387.07% | -111.98% | 409.27% | -47.64% |
| Cash from Operations | 0.00% | 28.97% | 7.47% | 45.98% | 9.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -40.00% | -11.11% | 25.00% | -9.09% |
| Issuance of Common Stock | 0.00% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 10,710.00% | -25.00% | -100.00% | -100.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 97.01% | 7.32% | -441.21% | -116.51% |